COCP READ THE FULL COCP RESEARCH REPORT Business Update Phase 1b Challenge Study of CDI-922 to be Initiated in 1H26 Cocrystal Pharma, Inc. (NASDAQ:COCP) is developing CDI-988 as a prophylaxis and ...
Neither the VDH nor the CDC are any longer reporting COVID fatalities or total cases in Vermont or in the US. The ...
Patients with rotavirus and norovirus, infectious diseases that mainly occur during winter, have recently been increasing.
China is entering the annual peak season for acute infectious diarrhea caused by pathogens such as norovirus and rotavirus, ...